Familial clustering for features of the metabolic syndrome: the National Heart, Lung, and Blood Institute (NHLBI) Family Heart Study
- PMID: 16505518
- DOI: 10.2337/diacare.29.03.06.dc05-0679
Familial clustering for features of the metabolic syndrome: the National Heart, Lung, and Blood Institute (NHLBI) Family Heart Study
Abstract
Objective: Metabolic syndrome-related traits (obesity, glucose intolerance/insulin resistance, dyslipidemia, and hypertension) have been shown to be genetically correlated. It is less clear, however, if the genetic correlation extends to novel risk factors associated with inflammation, impaired fibrinolytic activity, and hyperuricemia. We present a bivariate genetic analysis of MetS-related traits including both traditional and novel risk factors.
Research design and methods: Genetic correlations were estimated using a variance components procedure in 1,940 nondiabetic white individuals from 445 families in the National Heart, Lung, and Blood Institute (NHLBI) Family Heart Study. Twelve MetS-related traits, including BMI, waist circumference, blood pressure, white blood cell count, fasting serum triglycerides, HDL cholesterol, insulin, glucose, plasminogen activator inhibitor-1 antigen, uric acid, and C-reactive protein, were measured and adjusted for covariates, including lifestyle variables.
Results: Significant genetic correlations were detected among BMI, waist circumference, HDL cholesterol, triglycerides, insulin, and plasminogen activator inhibitor-1 antigen and between uric acid and all of the above variables except insulin. C-reactive protein and white blood cell count were genetically correlated with each other, and both showed significant genetic correlations with waist circumference and insulin. Fasting glucose was not significantly genetically correlated with any of the other traits.
Conclusions: These results suggest that pleiotropic effects of genes or shared family environment contribute to the familial clustering of MetS-related traits.
Publication types
MeSH terms
Substances
Grants and funding
- T32 HL 07972/HL/NHLBI NIH HHS/United States
- U01 HL 56563/HL/NHLBI NIH HHS/United States
- U01 HL 56564/HL/NHLBI NIH HHS/United States
- U01 HL 56565/HL/NHLBI NIH HHS/United States
- U01 HL 56566/HL/NHLBI NIH HHS/United States
- U01 HL 56567/HL/NHLBI NIH HHS/United States
- U01 HL 56568/HL/NHLBI NIH HHS/United States
- U01 HL 56569/HL/NHLBI NIH HHS/United States
- U01 HL 67893/HL/NHLBI NIH HHS/United States
- U01 HL 67894/HL/NHLBI NIH HHS/United States
- U01 HL 67895/HL/NHLBI NIH HHS/United States
- U01 HL 67896/HL/NHLBI NIH HHS/United States
- U01 HL 67897/HL/NHLBI NIH HHS/United States
- U01 HL 67898/HL/NHLBI NIH HHS/United States
- U01 HL 67899/HL/NHLBI NIH HHS/United States
- U01 HL 67900/HL/NHLBI NIH HHS/United States
- U01 HL 67901/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials